Skip to main content

Pulmonary Function Tests

  • Chapter

Abstract

Structural changes in the lungs elicit changes in pulmonary function. In most diffuse lung diseases, respiratory symptoms generally develop insidiously because of alterations of the elastic and/or the flow-resistive properties of the lungs. These symptoms occur concurrently with disturbances of gas exchange. Most of the time, the physiologic alterations occur concomitantly with radiologic changes, but in some cases, symptoms and physiologic disturbances may be present without evidence of radiologic alterations. Thus physiological assessment is necessary in the diagnostic evaluation and also in the management, evolution, and response to therapy of patients with diffuse lung diseases.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Quanjer H, Tammeling GJ, Cotes JE et al. (1993) Lung volumes and forced ventilatory flows. Official statement of the European Respiratory Society. Eur Respir J 6, suppl 16: 5–40.

    CAS  Google Scholar 

  2. American Thoracic Society (1995) Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 152: 1107–36.

    Google Scholar 

  3. American Thoracic Society (1991) Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144: 1202–18.

    Google Scholar 

  4. Eliasson O, Degraff AC (1985) The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, Spirometrie, and anthropometric variables. Am Rev Respir Dis 132: 858–864.

    PubMed  CAS  Google Scholar 

  5. Meslier N, Racineux JL (1991) Tests of reversibility of airflow obstruction. Eur Respir Rev 1: 34–40.

    Google Scholar 

  6. American Thoracic Society (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 152: S77–S120.

    Google Scholar 

  7. Ferris BG (1978) Epidemiology standardization project. Am Rev Respir Dis 118: 55–88.

    Google Scholar 

  8. Hyatt RF, Okeson GC, Rodarte JR (1973) Influence of expiratory flow limitation on the pattern of lung emptying in man. J Appl Physiol 35: 411–19.

    PubMed  CAS  Google Scholar 

  9. Rodarte JR, Hyatt RE, Cortese DA (1975) Influence of expiratory flow on closing capacity at low expiratory flow rates. J Appl Physiol 39: 60–5.

    PubMed  CAS  Google Scholar 

  10. Guerry-Force ML, Muller NL, Wright JL et al. (1987) A comparison of bronchitis obliterans with organizing pneumonia, usual interstitial pneumonia, and small airways disease. Am Rev Respir Dis 135: 705–12.

    PubMed  CAS  Google Scholar 

  11. Ries AL, Sosa G, Prewitt L et al. (1988) Restricted pulmonary function in cystic fibrosis. Chest 94: 575–9.

    Article  PubMed  CAS  Google Scholar 

  12. Bates DV (1989) Respiratory function in disease. 3rd ed. WB Saunders, Philadelphia.

    Google Scholar 

  13. Wilson AF (1985) ed. Pulmonary function testing, indications and interpretations. Grune & Stratton, Orlando, FL.

    Google Scholar 

  14. Burrows B, Knudson RJ, Quan SF et al. (1983) Respiratory disorders: a pathophysiologic approach. Year Book Medical Publishers, Chicago.

    Google Scholar 

  15. Enright PL, Hyatt RE (1987) Office spirometry: a practical guide to the selection and use of spirometers. Lea & Febiger, Philadelphia.

    Google Scholar 

  16. Bousey HA, Holtzman MJ, Shelle JR et al. (1980) Bronchial hyperreactivity. Am Rev Respir Dis 121: 389–413.

    Google Scholar 

  17. Sterk PJ, Bel EH (1991) The shape of the dose-response curve to inhaled bronchoconstrictor agents in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 143: 1433–7.

    PubMed  CAS  Google Scholar 

  18. Lung Health Study (1992) Am Rev Respir Dis 145: 301–10.

    Google Scholar 

  19. West JB (1988) Ventilation, blood flow, and gas exchange. In: Murray JF, Nadel JA, eds. Respiratory Medicine. WB Saunders Company pp. 47–84.

    Google Scholar 

  20. Function of the respiratory tract. In: Seaton A, Seaton D, Leitch AG, Crofton & Douglas’s respiratory diseases. Blackwell Scientific Publications, Oxford, pp. 28–75.

    Google Scholar 

  21. Weisman IM, Zeballos RJ (1996) Pulmonary function testing and mechanics. In: American College of Chest Physicians (ed) 11th National ACCP Pulmonary Board Review, pp. 79–94.

    Google Scholar 

  22. Geneva International Labour Organisation (1966) Respiratory function test in pneumoconiosis. Occupational safety and health series No. 6.

    Google Scholar 

  23. West JB (1974) Respiratory physiology. Williams and Wilkins, Baltimore.

    Google Scholar 

  24. Cherniack RM (1977) Pulmonary function testing. WB Saunders, Philadelphia.

    Google Scholar 

  25. Cherniack RM, Cherniack L (1983) Respiration in health and disease. WB Saunders, Philadelphia.

    Google Scholar 

  26. Cherniack RM (1983) Pulmonary ventilation, circulation and gas exchange. Semin Respir Med 4: 197–205.

    Article  Google Scholar 

  27. Cherniack RM (1988) Physiologie disturbances in interstitial lung disease. In: Schwarz MI, King Jr. TE, eds. Interstitial Lung Disease. BC Decker Inc. Toronto pp. 37–44.

    Google Scholar 

  28. Jackson LK, Fulmer JD (1988) Structural-functional features of the interstitial lung diseases. In: Fishman AP, ed. Pulmonary diseases and disorders. McGraw- Hill Book Company, New York pp. 739–54.

    Google Scholar 

  29. Crystal RG, Gadek JE, Ferrans VJ et al. (1981) Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med 70: 542–68.

    Article  PubMed  CAS  Google Scholar 

  30. Fulmer JD, Crystal RG (1979) Interstitial lung disease. In: Simmons, DE, ed. Current Pulmonology. Volume 1. Boston, Houghton-Mifflin, Professional Publishers.

    Google Scholar 

  31. Carrington CB, Gaensler EA, Mikus JP et al. (1978) Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 298: 801–9.

    Article  PubMed  CAS  Google Scholar 

  32. McCarthy D, Cherniack RM (1973) Regional ventilation-perfusion and hypoxia in cryptogenic fibrosing alveolitis. Am Rev Respir Dis 107: 200–8.

    PubMed  CAS  Google Scholar 

  33. Epier GR, Saber FA, Gaensler EA (1980) Determination of severe impairment (disability) in interstitial lung disease. Am Rev Respir Dis 121: 647–59.

    Google Scholar 

  34. Fulmer JD, Roberts WC, Von Gal ER et al. (1979) Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest 63: 665–76.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag London Limited

About this chapter

Cite this chapter

Bertorelli, G., Bocchino, V. (1999). Pulmonary Function Tests. In: Sperber, M. (eds) Diffuse Lung Disorders. Springer, London. https://doi.org/10.1007/978-1-4471-3440-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3440-4_4

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-3442-8

  • Online ISBN: 978-1-4471-3440-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics